FIELD: chemistry of metalloorganic compounds, medicine, oncology.
SUBSTANCE: invention relates to novel chemical compounds, namely, to complexes of palladium with heterocyclic ligands of the general formula (I): 
wherein R1 means-NH, oxygen atom (O), -CH2; R2 means two hydrogen atoms (2H), O; R3 means hydrogen atom H, CH3, CH2-CH2-NH2,-(CO)-CH3; X means chlorine (Cl), bromine (Br) atom; n = 1; m = 1 if R1 means -NH, O; R2 means 2H; R3 means H, CH3, CH2-CH2-NH2, -(CO)-CH3; n = 2; m = 1 if R1 means O, -CH2; R2 means O, 2H; R3 means H, CH3, -(CO)-CH3; n = 2; m = 3 if R1 means -NH; R2 means 2H; R3 means CH2-CH2-NH2 eliciting pharmacological, in particular, anti-tumor activity. Proposed compounds possess high activity and characterized by reduced toxicity as compared with anti-tumor preparations with platinum complexes.
EFFECT: valuable medicinal properties of complexes.
4 cl, 2 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CATION-ANIONIC COMPLEXES OF PALLADIUM | 2018 |
|
RU2699809C1 |
| COMPOUNDS ON THE BASIS OF PALLADIUM AND AROMATIC AMINE DERIVATIVES, AND A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2022968C1 |
| DICARBOXYLIC ACID BISAMIDE DERIVATIVES, THEIR APPLICATION, THE PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS FOR THEIR PRODUCTION | 2013 |
|
RU2665688C2 |
| BISAMIDES DERIVATIVE OF DICARBOXYLIC ACIDS, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, METHODS FOR PRODUCTION THEREOF | 2018 |
|
RU2725881C2 |
| TSPO DIPEPTIDE LIGANDS HAVING NEUROPSYCHOTROPIC ACTIVITY | 2018 |
|
RU2756772C2 |
| BICAMIDES DERIVATIVE OF DICARBOXYLIC ACIDS, USE THEREOF, A PHARMACEUTICAL COMPOSITION BASED THEREON, METHODS FOR PRODUCTION THEREOF | 2018 |
|
RU2721421C2 |
| DERIVATIVE OF BISAMIDES OF DICARBOXYLIC ACIDS, ITS USE, PHARMACEUTICAL COMPOSITION BASED ON IT, METHODS FOR ITS PRODUCTION | 2018 |
|
RU2719464C2 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACIDS, ITS USE, PHARMACEUTICAL COMPOSITION BASED ON IT, METHODS FOR ITS OBTAINING | 2020 |
|
RU2815401C2 |
| SUBSTITUTED BISDIPEPTIDE WITH NEUROPROTECTIVE AND ANTIDEPRESSANT EFFECT | 2014 |
|
RU2559880C1 |
| LEUCYLTRYPTOPHAN TSPO LIGANDS WITH ANXIOLYTIC ACTIVITY | 2020 |
|
RU2757476C2 |
